Screener
Sana Biotechnology SANA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $83,800 | $71,870 |
| Marketable securities | 17,336 | 66,512 |
| Restricted cash | 4,195 | 4,195 |
| Prepaid expenses and other current assets | 6,359 | 6,099 |
| Total current assets | 111,690 | 148,676 |
| Property and equipment, net | 25,673 | 26,906 |
| Operating lease right-of-use assets | 35,845 | 38,313 |
| Intangible asset | 59,195 | 59,195 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's prepaid & other current?
- Sana Biotechnology (SANA) reported prepaid & other current of $6.36M in Q1 2026.
- How has Sana Biotechnology's prepaid & other current changed year-over-year?
- Sana Biotechnology's prepaid & other current increased by 65.8% year-over-year, from $3.84M to $6.36M.
- What is the long-term trend for Sana Biotechnology's prepaid & other current?
- Over 4 years (2021 to 2025), Sana Biotechnology's prepaid & other current has grown at a -10.3% compound annual growth rate (CAGR), from $30.98M to $20.08M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Sana Biotechnology's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude